Showing results (421-430 of 782) with videos related to
Sort By:
Pageof 79
The Lancet. HIV|December 25, 2019
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIVRobert C Bollinger, Chloe L Thio, Mark S Sulkowski, et al.The Lancet. HIV|February 23, 2018
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration studyBeatriz Grinsztejn, Brenda Hoagland, Ronaldo I Moreira, et al.The Lancet. HIV|July 17, 2017
Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation studyKarl-Günter Technau, Louise Kuhn, Ashraf Coovadia, et al.The Lancet. HIV|March 2, 2018
Migration and risk of HIV acquisition in Rakai, Uganda: a population-based cohort studyOluwasolape Olawore, Aaron A R Tobian, Joseph Kagaayi, et al.The Lancet. HIV|October 22, 2016
Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trialAditya H Gaur, Hilda Kizito, Wasana Prasitsueubsai, et al.The Lancet. HIV|December 14, 2016
Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort studyGeorges Reniers, Sylvia Blom, Clara Calvert, et al.The Lancet. HIV|July 9, 2015
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort studyLisa M Noguchi, Barbra A Richardson, Jared M Baeten, et al.The Lancet. HIV|July 30, 2016
Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysisAmit C Achhra, Gwamaka Mwasakifwa, Janaki Amin, et al.Pageof 79